Intravenous immunoglobulins (IVIGs) are used for a variety of immunologic and hematologic disorders. Hemorheologic alteration or the rapid increase of platelet counts by IVIG administration can cause thrombotic adverse events. We present a 58-year-old woman with a previous diagnosis of idiopathic thrombocytopenic purpura who developed cerebellar infarction immediately after IVIG treatment. We discuss a possible role of IVIG in cerebral ischemia and management strategies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2012.05.006 | DOI Listing |
Publication Analysis
Top Keywords
cerebellar infarction
8
idiopathic thrombocytopenic
8
thrombocytopenic purpura
8
acute cerebellar
4
infarction associated
4
associated intravenous
4
intravenous gammaglobulin
4
gammaglobulin treatment
4
treatment idiopathic
4
purpura intravenous
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!